Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-02-06 Sale | 2020-02-07 8:25 pm | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 9,264 | $229.93 | $2,130,079 | 39,700 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-13 Option Award | 2024-06-14 4:16 pm | N/A 2034-06-12 | Neumora Therapeutics Inc. | NMRA | Piacquad David Director | 48,671 | $0 | 48,671 (Direct) | View |
2023-09-14 Option Award | 2023-09-18 5:56 pm | N/A 2033-09-13 | Neumora Therapeutics Inc. | NMRA | Piacquad David Director | 46,455 | $0 | 46,455 (Direct) | View |
2021-04-30 Option Award | 2021-05-04 7:38 pm | 2023-04-30 2031-04-30 | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 6,868 | $0 | 50,946 (Direct) | View |
2021-05-01 Tax Withholding | 2021-05-04 7:38 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 359 | $239.64 | 50,946 (Direct) | View |
2021-04-27 Tax Withholding | 2021-04-28 8:14 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 128 | $255.52 | 44,437 (Direct) | View |
2021-03-19 Tax Withholding | 2021-03-22 6:33 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 991 | $244.42 | 44,565 (Direct) | View |
2021-03-02 Option Award | 2021-03-04 8:33 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 2,648 | $0 | 45,504 (Direct) | View |
2020-05-05 Option Award | 2020-05-07 9:03 pm | 2022-05-05 2030-05-05 | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 11,897 | $0 | 53,401 (Direct) | View |
2020-05-01 Tax Withholding | 2020-05-05 7:55 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 123 | $239.22 | 41,504 (Direct) | View |
2020-05-03 Tax Withholding | 2020-05-05 7:55 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 136 | $230.98 | 41,504 (Direct) | View |
2020-04-27 Tax Withholding | 2020-04-29 7:02 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 116 | $236.28 | 41,763 (Direct) | View |
2020-03-20 Tax Withholding | 2020-03-24 6:03 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 1,591 | $198.76 | 41,879 (Direct) | View |
2020-03-03 Option Award | 2020-03-05 7:52 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 3,711 | $0 | 43,411 (Direct) | View |
2019-12-13 Tax Withholding | 2019-12-13 8:31 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 2,425 | $235.99 | 54,803 (Direct) | View |
2019-12-13 Exercise | 2019-12-13 8:31 pm | 2019-05-01 2027-05-01 | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 2,875 | $0 | 54,803 (Direct) | View |
2019-12-13 Exercise | 2019-12-13 8:31 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 2,875 | $162.6 | 54,803 (Direct) | View |
2019-11-20 Tax Withholding | 2019-11-20 8:09 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 4,870 | $224.5 | 51,453 (Direct) | View |
2019-11-20 Exercise | 2019-11-20 8:09 pm | N/A N/A | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 5,749 | $156.35 | 51,453 (Direct) | View |
2019-11-20 Exercise | 2019-11-20 8:09 pm | 2018-05-03 2026-05-03 | AMGEN INC | AMGN | Piacquad David SVP, Business Development | 5,749 | $0 | 51,453 (Direct) | View |